10 September 2024
\n \n \n \nScientists from the Centre for Human Genetics at Nuffield Department of Medicine are taking the initial steps in developing the UK\u2019s first vaccine to prevent cancer in people with Lynch syndrome, thanks to funding from Cancer Research UK.
\n \n\n \n \n12 August 2024
\n \n \n \nThe Pandemic Sciences Institute, in collaboration with the Ethox Centre, has supported a new exhibition at Oxford\u2019s History of Science Museum. The exhibition, entitled \"A Healthy Future for All?\", explores the science driving advancements in healthcare
\n \n\n \n \n16 July 2024
\n \n \n \nC\u00f4te d\u2019Ivoire will become the first country to roll-out the new R21/Matrix-M\u2122 vaccine with the first child vaccinated in Abidjan, marking a critical step and historic milestone in the global fight against malaria. 15 African countries are expected to introduce malaria vaccines with Gavi support in 2024, and countries plan to reach around 6.6 million children with the malaria vaccine in 2024 and 2025. The new vaccine has been authorised by Ghana, Nigeria, Burkina Faso and the Central African Republic, and many others are preparing to receive shipments.
\n \n\n \n \n6 June 2024
\n \n \n \nMany congratulations to Dr Caesar Atuire who has been appointed President of the International Association of Bioethics.
\n \n\n \n \n27 May 2024
\n \n \n \nThe Minister of Health and Family Welfare of Bangladesh, the Honourable Dr Samanta Lal Sen, and the Bangladesh High Commissioner to the UK, Her Excellency Ms Saida Muna Tasneem, paid a visit to the Centre for Medicines Discovery at NDM last week.
\n \n\n \n \n23 May 2024
\n \n \n \nResearchers from the Pandemic Sciences Institute at NDM are launching a new computer simulations project to model vaccine clinical trial designs and strengthen global response to pandemic threats.
\n \n\n \n \n21 May 2024
\n \n \n \nThe Academy of Medical Sciences has elected two medical scientists from the Nuffield Department of Medicine to its fellowship in 2024.
\n \n\n \n \n16 May 2024
\n \n \n \nTwo academics from the Nuffield Department of Medicine have joined the Royal Society as Fellows.
\n \n\n \n \n3 May 2024
\n \n \n \nProfessor Yang Shi from the Ludwig Institute for Cancer Research at NDM has been elected as a member of the National Academy of Sciences in the United States.
\n \n\n \n \n2 May 2024
\n \n \n \nFor Skin Cancer Awareness Month, the Ludwig Institute for Cancer Research looks at recent research into melanoma from Professors Richard White, Professor of Genetics, and Colin Goding, Professor of Oncology.
\n \n\n \n \n30 April 2024
\n \n \n \nThe Oxford immunology community celebrated the donation of Sir Peter Medawar\u2019s Nobel Prize medal to the University.
\n \n\n \n \n29 April 2024
\n \n \n \nA randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 patients in Madagascar, marking a critical milestone in evidence generation for plague treatments.
\n \n\n \n \n25 April 2024
\n \n \n \nResearchers from the Jenner Institute at NDM will present new exciting data on the R21/Matrix-M malaria vaccine during the 8th Pan-African Malaria Conference, in collaboration with the Rwandan Ministry of Health and the Rwanda Biomedical Centre.
\n \n\n \n \n15 April 2024
\n \n \n \nThe Chinese Ambassador to the United Kingdom, His Excellency Zheng Zeguang, visited the University of Oxford last week, where he promoted deeper educational exchanges between China and the UK. During the visit, Zheng met with Irene Tracey, Vice-Chancellor of the university, and had an in-depth discussion on the university\u2019s collaboration with Chinese counterparts.
\n \n\n \n \n8 April 2024
\n \n \n \nDr Francesco Boccellato, Leadership Fellow at the Oxford Branch of the Ludwig Institute for Cancer Research has recently been awarded the Lee Placito Research Fellowship in Gastrointestinal Cancer.
\n \n\n \n \n5 April 2024
\n \n \n \nResearchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.
\n \n\n \n \n4 April 2024
\n \n \n \nIn the first week of April each year, the global community comes together to celebrate health workers, the backbone of the health industry and society.
\n \n\n \n \n26 March 2024
\n \n \n \nResearchers at the Nuffield Department of Medicine, the Francis Crick Institute and University College London have been granted \u00a31.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine. The group includes Professor Tim Elliott, Kidani Professor of Immuno-oncology at NDM.
\n \n\n \n \n25 March 2024
\n \n \n \nThe Centre for Medicines Discovery (CMD) at NDM, has recently partnered with Ono Pharmaceutical Co (Ono) to validate and develop novel targets in a bid to discover innovative medicines.
\n \n\n \n \n21 March 2024
\n \n \n \nThe Pandemic Sciences Institute at NDM, in collaboration with the global coalition of health research funders GloPID-R and UKCDR, has launched a new research programme including an interactive platform to track and analyse over $7 billion in global pandemic research funding.
\n \n\n \n \n